Sign inSubmit
ArticleMetrics
Research Article · Open access · Published 2 November 2022

Exploring the Role of Immune Complexes in Essential Hypertension

Ivan Milosevic1

American Journal of Immunology, Volume 18, Issue 1, pp. 1–4 · doi.org/10.3844/ajisp.2022.1.4

9,974 accesses4,615 downloads0 citations (Crossref)Metrics
Cite Check for updates

Abstract

Essential hypertension is a rise of arterial blood pressure whose etiology is unknown. Immune complexes are complexes created by the binding of an antibody to the antigen. They are also called circulating immune complexes because of its precipitation in peripheral blood vessels, commonly on the places of their bifurcation and the places of higher blood pressure (glomerules of kidney or synovia). The goal of this study is to, by statistical estimation, connect essential hypertension and immune complexes as a cause of many appearances. With this aim, two groups of twenty-five examinees were questionnaire about their frequency and how long they ailed acut streptococcal tonsillitis, which may latter cause poststreptococcal glomerulonephritis as a consequence of immune complex creation. In doing so, examinees were also questionnaired about immune complex diseases (Systemic Lupus Erythematosus (SLE), Polynodosa Arteritis (PA), and Poststreptococcal Glomerulonepritis (PSG)). After all, they were questionnaired, about how frequently and how long they used penicillin as a therapy, which also may, in certain occasions, affect the creation of immune complexes. Examined groups were formed by patients suffering from essential hypertension, and the control groups were formed by randomly chosen examinees. By statistical estimating data from the mentioned questionnaire, we concluded that the frequency of past acute streptococcal tonsillitis in patients with essential hypertension has statistical significance and the frequency of past or actual immune complex diseases (SLE, PA, PSG); and using penicillin as a therapy does not have statistical significance.

Licence and reuse

Open access. This article is licensed under a Creative Commons Attribution 4.0 International Licence (CC BY 4.0), as printed on the article, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original authors and the source. No permission is needed.

How to reuse this article

Responses (0)

Have a comment on this research? Sign in to respond. Responses are moderated and published with your name and affiliation; the authors are invited to reply. How we use your dataWrite a response

About this article

Cite this article

Milosevic, I. (2022). Exploring the Role of Immune Complexes in Essential Hypertension. American Journal of Immunology, 18(1), 1–4. https://doi.org/10.3844/ajisp.2022.1.4

Licence
CC BY 4.0
Issue
Volume 18, Issue 1
Policies
Editorial independenceUse of generative AIData availabilityAppeals and complaints
Version
Version of record
Exploring the Role of Immune Complexes in Essential HypertensionAmerican Journal of Immunology · Volume 18, Issue 1 · pp. 1–4 · CC BY 4.0Download